- Home
- NXPLW vs HASI Comparison
NXPLW vs HASI Comparison
Compare NXPLW & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPLW
- HASI
- Stock Information
- Founded
- NXPLW N/A
- HASI 1981
- Country
- NXPLW United States
- HASI United States
- Employees
- NXPLW 166
- HASI N/A
- Industry
- NXPLW Telecommunications Equipment
- HASI Real Estate Investment Trusts
- Sector
- NXPLW Telecommunications
- HASI Real Estate
- Exchange
- NXPLW Nasdaq
- HASI Nasdaq
- Market Cap
- NXPLW N/A
- HASI N/A
- IPO Year
- NXPLW N/A
- HASI 2013
- Fundamental
- Price
- NXPLW $0.23
- HASI $29.06
- Analyst Decision
- NXPLW
- HASI Strong Buy
- Analyst Count
- NXPLW 0
- HASI 12
- Target Price
- NXPLW N/A
- HASI $40.25
- AVG Volume (30 Days)
- NXPLW 6.4K
- HASI 1.1M
- Earning Date
- NXPLW 03-31-2025
- HASI 05-06-2025
- Dividend Yield
- NXPLW N/A
- HASI 5.78%
- EPS Growth
- NXPLW N/A
- HASI 14.02
- EPS
- NXPLW N/A
- HASI 1.62
- Revenue
- NXPLW $66,482,000.00
- HASI $140,172,000.00
- Revenue This Year
- NXPLW N/A
- HASI $189.54
- Revenue Next Year
- NXPLW N/A
- HASI $11.80
- P/E Ratio
- NXPLW N/A
- HASI $17.96
- Revenue Growth
- NXPLW 179.89
- HASI 2.29
- 52 Week Low
- NXPLW $0.25
- HASI $24.00
- 52 Week High
- NXPLW $0.26
- HASI $36.56
- Technical
- Relative Strength Index (RSI)
- NXPLW N/A
- HASI 50.40
- Support Level
- NXPLW N/A
- HASI $29.14
- Resistance Level
- NXPLW N/A
- HASI $29.48
- Average True Range (ATR)
- NXPLW 0.00
- HASI 0.60
- MACD
- NXPLW 0.00
- HASI -0.05
- Stochastic Oscillator
- NXPLW 0.00
- HASI 45.22
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.